Fox Chase Cancer Center Signs Agreement with Life Technologies Corporation Fox Chase Cancer Center announced it has entered into an agreement with Life Technologies Corporation that will underpin a new program to provide next-generation sequencing analysis of solid tumors. [Fox Chase Cancer Center Press Release] Sanofi Enters into Research Collaboration with Biopharmaceutical Company Audion Therapeutics to Develop Potential Treatments for Hearing Loss Sanofi announced that it has entered into a two-year research collaboration with the biopharmaceutical company Audion Therapeutics to develop potential treatments for hearing loss through the optimization of small molecules by using a regenerative medicine approach. [Sanofi Press Release] National Eye Institute Awards Cedars-Sinai $3 Million to Develop Gene, Stem Cell Therapies for Corneal Disease Cedars-Sinai stem cell researchers investigating ways to prevent eye problems in diabetic patients have been awarded a $3 million grant from the National Eye Institute to develop gene therapy in corneal stem cells to alleviate damage to corneas that can cause vision loss. [Cedars-Sinai Press Release]
BrainStorm Initiates Clinical Trials and Holds Successful Shareholders Meeting BrainStorm Cell Therapeutics announced that together with the Hadassah Medical Organization, a successful study initiation/clinical trial kickoff meeting was held at the Hadassah Medical Center and with this meeting the trial is underway. [BrainStorm Cell Therapeutics Press Release]
Adaptimmune Announces Opening of Phase I/II Clinical Trial for Metastatic Melanoma Adaptimmune announced that it has opened a Phase I/II, two cohort, open label clinical trial in metastatic melanoma at Washington University. [Adaptimmune Press Release] ACT Announces First Patients Enrolled in Two Clinical Trials Using Embryonic Stem Cells to Treat Stargardt’s Disease and Dry Age-Related Macular Degeneration Advanced Cell Technology, Inc. (ACT) announced the enrollment of the first patients in its two Phase I/II clinical trials for Stargardt’s Macular Dystrophy and Dry Age-Related Macular Degeneration using retinal pigment epithelial cells derived from human embryonic stem cells. [Advanced Cell Technology, Inc. Press Release]
Alnylam Appoints Akshay Vaishnaw as Chief Medical Officer Alnylam Pharmaceuticals, Inc. announced that it has promoted Akshay K. Vaishnaw, M.D., Ph.D., to the new position of Chief Medical Officer. [Alnylam Pharmaceuticals, Inc. Press Release] Micromet Appoints Ulrich Grau, Ph.D. Executive Vice President and Chief Operating Officer Micromet, Inc. announced the appointment of Ulrich Grau, Ph.D., as Executive Vice President, Chief Operating Officer. [Micromet, Inc. Press Release] King’s Appoints Stem Cell Expert to Lead New Center King’s College London announced that it is set to launch a Centre for Stem Cells & Regenerative Medicine to be led by Professor Fiona Watt, former president of the International Society of Stem Cell Research. [King’s College London Press Release] New Centre to Drive Commercialization of Regenerative Medicine A network of Canadian scientists, entrepreneurs and industry partners launched a new centre aimed at translating regenerative medicine science into marketable products that will revolutionize medicine. [The Centre for Commercialization of Regenerative Medicine Press Release] Nuvilex Enters Discussions to Acquire Next Generation Technology to Treat Multiple Types of Cancer Nuvilex, Inc. announced it has entered into discussions to acquire the next generation live cell encapsulation technology that serves as the platform for multiple cancer therapies. [Nuvilex, Inc. Press Release] NUI Galway, UL and UCC Partner in PhD Program Research in the area of Biomedical Engineering and Regenerative Medicine will be furthered through the launch of a structured PhD Program in the field delivered through the National University of Ireland (NUI) Galway/UL Strategic Alliance and University College Cork (UCC). [National University of Ireland Galway Press Release] Stem Cell Scientific Leader Awarded Prestigious Taylor Prize The University of Western Ontario announced this year’s recipient of the J. Allyn Taylor International Prize in Medicine is Dr. Rudolf Jaenisch, a founding member of the Whitehead Institute for Biomedical Research and Professor of Biology at the Massachusetts Institute of Technology. [University of Western Ontario Press Release] UCSF Stem Cell, Cancer Scientist Honored for Pioneering Studies University of California, San Francisco (UCSF)’s Robert Blelloch, MD, PhD, has received the 2011 Outstanding Young Investigator Award from the International Society for Stem Cell Research, for his pioneering research on the role of molecular tools known as microRNAs in embryonic stem cells and cancer. [University of California, San Francisco Press Release] |